A gut-bacteria protocol improved sleep in an insomnia trial

In a trial in the Journal of Internal Medicine, 80 adults with chronic insomnia took either a gut-bacteria protocol or a placebo. The protocol group slept more soundly, but it also included antibiotics, so the trial cannot say a stool transplant alone did it.

Based on a peer-reviewed study in the Journal of Internal Medicine

Summary

In a multicenter, randomized, double-blind, placebo-controlled trial, 80 adults with chronic insomnia disorder were split evenly between a fecal microbiota transplant (FMT) protocol and a placebo (40 people each).
Measured overnight by polysomnography, the FMT protocol improved sleep efficiency (the share of time in bed spent asleep) by 13.9 percentage points versus placebo (95% CI 7.29 to 20.41; p = 0.003) and reduced wake after sleep onset.
Self-reported scores on the Insomnia Severity Index and the Pittsburgh Sleep Quality Index showed sustained improvement from 2 to 6 months after treatment.
The FMT group received short-course antibiotics before the donor capsules; the placebo group received neither, so the trial cannot separate the transplant's effect from the antibiotics or the two combined.
The treatment was well tolerated, with mild, self-limited side effects and no serious adverse events, but this is early evidence from one 80-person trial, the full paper is paywalled, and FMT is a supervised medical procedure, not a home remedy.

Chronic insomnia grinds people down, and the standard tools, sleeping pills and talk therapy, do not work for everyone. Some researchers have started to wonder whether part of the answer sits lower down, in the community of bacteria that lives in the gut.

Now a randomized trial, published in the Journal of Internal Medicine, has tested a fecal microbiota transplant protocol, capsules of screened donor stool meant to reseed the gut, in 80 adults with chronic insomnia disorder. The patients who received it slept measurably better than those given a placebo, and the difference showed up on an overnight lab recording, beyond what they simply reported feeling.

There is a catch worth stating up front. The protocol did not begin with the capsules; it began with a short course of antibiotics, which the comparison group never got. That bundling shapes what the study can and cannot prove.

What the two groups took

Insomnia is common, and current treatments remain limited, which is why a team went looking somewhere unusual. The result offers new evidence, from a controlled experiment, that reshaping gut bacteria might change how well people sleep.

The design itself was solid. It was a multicenter, randomized, double-blind, placebo-controlled trial, meaning patients were assigned by chance and neither they nor the staff scoring their sleep knew who got the real capsules. The two arms started differently. One took a short course of antibiotics and then swallowed capsules of donor gut bacteria; the other took placebo capsules without antibiotic pretreatment.

That difference is the study’s blind spot. Because only the transplant arm also received antibiotics, there is no clean way to tell whether the donor bacteria improved sleep, whether the antibiotics did, or whether the two only work together. The study shows that the whole package beat a placebo. It cannot single out the stool capsules.

How much their sleep changed

Sleep here was recorded in a lab with polysomnography, an overnight trace of brain waves, breathing and movement, so the results did not rest on how patients remembered their nights. A month after treatment, the transplant group’s sleep efficiency, the share of time in bed actually spent asleep, ran about 14 percentage points higher than the placebo group’s, and they spent less time awake after first drifting off, a measure researchers call wake after sleep onset.

The gains patients reported on their own held up as well. On two standard questionnaires, the Insomnia Severity Index and the Pittsburgh Sleep Quality Index, scores stayed better for months after treatment. As sleep trials go, a change of that size is large. It also rests on 80 people at a handful of clinics, so it will need repeating before anyone leans on it.

Why the gut might touch sleep

The study offers a clue about why, though not proof. In those who got the transplant, the treatment raised microbial richness and diversity, a broader and more varied mix of gut microbes. The thinking is that a richer gut community changes the chemical and nerve signals that pass between the gut and the brain, and that this could reach into sleep. It was not built to test that pathway, so for now it stays a hypothesis.

One more detail points to future work. The patients it helped and those it did not differed in baseline microbiota composition, the makeup of their gut bacteria before treatment, which the authors flag as exploratory.

What it actually means

Add it up, and the honest read is that this is early work. It is a single trial of 80 people, the objective sleep gain was captured a month out, and the full paper is paywalled, so independent readers have the summary, not the full method and limitations. And, as already noted, bundling antibiotics with the capsules makes it impossible to credit the transplant on its own.

None of this is a reason to experiment on your own gut. A fecal transplant is a medical procedure with real risks, including passing along an infection, and it belongs in a clinic with a carefully screened donor. Store-bought probiotics are a different thing entirely, and they were not part of this study. If your nights are a mess, the useful next move is still a doctor, not a stool capsule.

For now this is a protocol worth testing in bigger trials, not a shortcut anyone should try at home.